Abstract
Background-The ODYSSEY OUTCOMES (Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome) trial demonstrated that alirocumab reduced majo......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
